Stopped: The trial prematurely terminated due to the inability to recruit the planned number of participants. The decision to terminate the trial was not based on any safety and/or efficacy concerns.
The purpose of this study is to learn about the treatments used in for advanced renal cell carcinoma as well as effectiveness of these treatments in the real world. Study participants must be: At least 18 years of age or older. Confirmed renal cell carcinoma Received first line treatment
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Progression Free Survival (PFS)
Timeframe: From treatment initiation date until PD, death or end of follow-up period whichever was earlier (maximum follow-up of 47.1 months)
PFS Rate at Month 6
Timeframe: 6 months post treatment initiation date (during maximum follow-up of 47.1 months)
PFS Rate at Month 9
Timeframe: 9 months post treatment initiation date (during maximum follow-up of 47.1 months)
PFS Rate at Month 12
Timeframe: 12 months post treatment initiation date (during maximum follow-up of 47.1 months)
PFS Rate at Month 18
Timeframe: 18 months post treatment initiation date (during maximum follow-up of 47.1 months)